Health system intelligence profile
Northwell Health
Editorially verified · Last reviewed August 30, 2026
Intelligence summary
Established 2013
Official objectives include incubating internal innovation, forming joint ventures and co-development programs, and running pilot trials with external organizations.
Mandate and remit
Northwell Holdings is the official for-profit investment and commercialization arm of Northwell Health. The health system's Holdings pages state that the unit invests in early-stage and growth opportunities, forms strategic partnerships, and cultivates internal innovations that can create diversified revenue streams. Official copy says Holdings develops and commercializes internal innovations invented by Northwell team members, brings products and medical devices to market, advances data assets, and forms joint ventures. An overview page states that Northwell Holdings was established in 2013 and that its strategy seeks private-equity and venture-class returns from companies that can diversify revenue and add contribution margin. Richard Mulry is publicly identified as President and CEO of Northwell Holdings. Separate official materials describe the Center for Learning and Innovation as Northwell's corporate university and the home of a 3D design and innovation lab, and they describe a system Innovation Challenge. This profile treats Holdings as the primary commercialization vehicle and notes the learning-and-innovation functions as related program elements. It does not evaluate financial returns.
These routes appear in the program's sourced public record.
For-profit arm focused on early-stage and growth investing, internal innovation commercialization, joint ventures, and data-asset development.
Center for Learning and Innovation
Officially described as Northwell's corporate university. The 2025 research and education report states that CLI houses Northwell's 3D design and innovation lab.
Northwell Innovation Challenge
Becker's Healthcare reported that Northwell's 2025 Innovation Challenge awarded $1.3 million to three employee-led projects and that the challenge launched in 2017.
Fund or office: Northwell Holdings
Official pages state that Holdings invests in early-stage innovative companies with strategic alignment to Northwell's goals and prefers Seed, Series A, and Series B rounds while remaining stage-agnostic when needed.
Official pages reviewed for this profile do not publish a complete current portfolio list. A Northwell news item linked from the Holdings page describes Ascertain, a company-creation platform launched with Aegis Ventures.
Official objectives include incubating internal innovation, forming joint ventures and co-development programs, and running pilot trials with external organizations.
Internal innovations and medical devices
Official Holdings copy states that the team develops and commercializes internal innovations and creates new products and medical devices through internal innovation and strategic partnerships.
Ascertain
A news item featured on the official Holdings page states that Northwell Health and Aegis Ventures launched a company-creation platform called Ascertain.
Organizational home: Northwell Holdings, Northwell Health
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Albany, New York
Office of Translational Research, Innovation, and Technology Transfer (OTR)
The Office of Translational Research, Innovation, and Technology Transfer supports Albany Medical College inventors in moving biomedical discoveries toward commercialization.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
New York, New York
Columbia Technology Ventures
Columbia Technology Ventures (CTV) is the technology transfer and commercialization office for Columbia University, including its medical center faculty and clinicians.
Academic · Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
New York, New York
Office of Entrepreneurship and Commercialization (OEC)
The Office of Entrepreneurship and Commercialization is Memorial Sloan Kettering's technology commercialization arm, renamed from the Office of Technology Development in October 2024.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
New York, New York
Mount Sinai BioDesign
Mount Sinai BioDesign is a medical device innovation incubator embedded in the Mount Sinai Health System that turns clinical insights from its physicians and surgeons into commercially viable medical technologies.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
New York, New York
i3 Asset Accelerator
The i3 Asset Accelerator is Mount Sinai Innovation Partners' milestone-driven investment program for advancing discoveries by Mount Sinai faculty, physicians and researchers toward commercial viability.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
New York, New York
Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP) is the commercialization organization for the Mount Sinai Health System and the Icahn School of Medicine, handling patenting, licensing, research partnerships and entrepreneurship.
Academic · Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.